Ketazolam
From Wikipedia, the free encyclopedia
|
Ketazolam
|
|
| Systematic (IUPAC) name | |
| ? | |
| Identifiers | |
| CAS number | |
| ATC code | N05 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C20H17ClN2O3 |
| Mol. mass | 368.8 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Half life | ? |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Schedule IV(US) |
| Routes | Oral |
Ketazolam (marketed under brand names Anseren, Anxon, Contamex, Loftran, Marcen, Sedotime, Solatran, Unakalm) is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties.
Ketazolam is not approved for sale in the United States or Canada. In South Africa, GlaxoSmithKline markets ketazolam under its Solatran trademark.[1] The U.S. Food and Drug Administration warns[2] that in Spain, ketazolam marketed as Marcen may sometimes be mistakenly confused with Narcan.
| NAME |
COUNTRY |
| Anseren |
Italy |
| Ansieten |
Argentina |
| Ansietil |
Chile |
| Marcen |
Spain |
| Sedatival |
Chile |
| Solatran |
South Africa, Bélgica, Suíça |
| Sedotime |
Spain |
| Unakalm |
Portugal, Países Baixos |
U 28774; Anxon;[3] Contamex; Loftran; DEA No. 2772[4];
Adinazolam, Alprazolam, Bentazepam, Bromazepam, Brotizolam, Camazepam, Chlordiazepoxide, Cinolazepam, Clobazam, Clonazepam, Clorazepate, Clotiazepam, Cloxazolam, Cyprazepam, Diazepam, Doxefazepam, Estazolam, Ethyl loflazepate, Etizolam, Fludiazepam, Flunitrazepam, Flurazepam, Flutazolam, Flutoprazepam, Gidazepam, Halazepam, Haloxazolam, Ketazolam, Loprazolam, Lorazepam, Lormetazepam, Medazepam, Mexazolam, Midazolam, Nimetazepam, Nitrazepam, Nordazepam, Oxazepam, Oxazolam, Phenazepam, Pinazepam, Prazepam, Quazepam, Temazepam, Tetrazepam, Tofisopam, Triazolam, Zolazepam